Back
ESC2025 Premium Access

Cardiovascular risks of ibuprofen versus naproxen: a target trial emulation

Session: Improving pharmacotherapy in primary prevention
Topic: Cardiotoxicity of Drugs
Speaker: Doctor A. Bech-Drewes (Aarhus, DK)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Anne Bech-Drewes

Aarhus University Hospital, Aarhus (Denmark)
0 follower

5 more presentations in this session

Lipid management in high cardiovascular risk patients without prior myocardial infarction or stroke - preliminary data from the VESALIUS-REAL global burden study

Speaker: Doctor Q. Chan (Greater London, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Lower rate of ischemic events with alirocumab in patients with atherosclerotic cardiovascular disease but without prior acute ischemic events

Speaker: Professor D. Bhatt (New York, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Aspirin for the primary prevention of major adverse cardiovascular events in patients with elevated lipoprotein(a): a meta-analysis

Speaker: Doctor P. Lee (Bronx, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Efficacy of inclisiran in patients affected by familial hypercholesterolemia: data from CHOLINET Registry

Speaker: Doctor C. Cotticelli (Naples, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Cardiorenal protective therapy for CKD: Real world data from the Hellenic Cardiorenal Morbidity Snapshots (HECMOS)

Speaker: Doctor I. Leontsinis (Athens, GR)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Improving pharmacotherapy in primary prevention

Speakers: Doctor A. Bech-Drewes, Doctor Q. Chan, Professor D. Bhatt, Doctor P. Lee, Doctor C. Cotticelli...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources